#Aids2026: Three HIV announcements South Africa made in Rio
South Africa returned from the International Aids Conference in Rio with three big HIV announcements: a new dashboard tracking the roll-out of the country's six-monthly HIV prevention injection, progress towards making the jab locally, and a licence for Aspen Pharmacare to make a promising monthly HIV prevention pill. Here's what these developments could mean for the future of HIV prevention in…
South Africa unveiled a new dashboard to track the roll-out of HIV prevention medicine at the International Aids Conference in Rio, with nearly 36,000 HIV-negative people having taken the six-monthly injection, Lenacapavir (LEN), by August 3rd. Of these, a quarter were pregnant or breastfeeding women, a high-risk group for HIV transmission.
Aspen Pharmacare secured a licence to manufacture a promising monthly HIV prevention pill, beating the requirement of pre-study data, while progress towards local manufacturing of LEN is underway, with a shortlist of potential producers now in Gilead Sciences’ hands.
Brief written by urgent.news from Bhekisisa's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
